Review: Microparticles in atrial fibrillation: A link between cell activation or apoptosis, tissue remodelling and thrombogenicity

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 660-669

  Jesel, L ^a   Abbas, M ^a,b   Toti, F ^a   Cohen, A ^c   Arentz, T ^d   Morel, O ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Lebanon University   (Lebanon)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Endothelium; Leukocytes; Platelet; Pulmonary vein isolation; Stroke; Thrombosis

Indexed keywords

ANIMAL; APOPTOSIS; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HUMAN; LEUKOCYTE; MEMBRANE MICROPARTICLE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PULMONARY VEIN ISOLATION; REVIEW; SHEAR STRENGTH; THROMBOCYTE; THROMBOSIS;

ENDOTHELIUM; LEUKOCYTES; PLATELET; PULMONARY VEIN ISOLATION; STROKE; THROMBOSIS;

ANIMALS; APOPTOSIS; ATRIAL FIBRILLATION; ATRIAL REMODELING; CELL-DERIVED MICROPARTICLES; HUMANS; OXIDATIVE STRESS; SHEAR STRENGTH; THROMBOSIS;

EID: 84885330542     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.031     Document Type: Review

References (82)

1. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006;26:2594-604.
2. Ederhy S, Di Angelantonio E, Mallat Z, et al. Levels of circulating procoagulant microparticles In nonvalvular atrial fibrillation. Am J Cardiol 2007;100:989-94.
3. Choudhury A, Chung I, Blann AD, Lip GY. Elevated platelet microparticle levels In nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest 2007;131:809-15.
4. Chirinos JA, Castrellon A, Zambrano JP, et al. Digoxin use Is associatedwith Increased platelet and endothelial cell activation In patients with nonvalvular atrial fibrillation. Heart Rhythm 2005;2:525-9.
5. Jesel L, Morel O, Pynn S, et al. Radiofrequency catheter ablation of atrial flutter Induces the release of platelet and leukocyte-derived procoagulant microparticles and a prothrombotic state. Pacing Clin ElectroPhysiol 2009;32:193-200.
6. Ederhy S, Dufaitre G, Boyer-Chatenet L, et al. Should all patients with non-valvular atrial fibrillation be anticoagulated? Int J Cardiol 2010;143:8-15.
7. Lee YJ, JyW, Horstman LL, et al. Elevated platelet microparticles In transient Ischemic attacks, lacunar Infarcts, andmultiinfarct dementias. Thromb Res 1993;72:295-304.
8. Simak J, GeldermanMP, Yu H,Wright V, Baird AE. Circulating endothelialmicroparticles In acute Ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-302.
9. Lee ST, Chu K, Jung KH, et al. Circulating CD62E(+) Microparticles and cardiovascular outcomes. PLoS One 2012;7:e35713.
10. LukasikM, RozalskiM, Luzak B, Michalak S, Kozubski W,Watala C. Platelet activation and reactivity In the convalescent phase of Ischaemic stroke. Thromb Haemost 2010;103:644-50.
11. Morel O, Jesel L, Freyssinet JM, Toti F. Cellularmechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011;31:15-26.
12. Bukowska A, Lendeckel U, Bode-Boger SM, Goette A. Physiologic and pathoPhysiologic role of calpain: Implications for the occurrence of atrial fibrillation. Cardiovasc Ther 2012;30:e115-27.
13. Aime-Sempe C, Folliguet T, Rucker-Martin C, et al.Myocardial cell death In fibrillating and dilated human right atria. J Am Coll Cardiol 1999;34:1577-86.
14. Kim NH, Ahn Y, Oh SK, et al. Altered patterns of gene expression In response to chronic atrial fibrillation. Int Heart J 2005;46:383-95.
15. Watson T, Shantsila E, Blann A, Lip GY. Circulating progenitor cells In patients with atrial fibrillation and their relation with serum markers of Inflammation and angiogenesis. Thromb Haemost 2010;104:327-34.
16. Ak K, Akgun S, Tecimer T, et al. Determination of histopathologic risk factors for postoperative atrial fibrillation In cardiac surgery. Ann Thorac Surg 2005;79:1970-5.
17. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate In experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003;60:315-25.
18. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997;89:2429-42.
19. Bombeli T, Schwartz BR, Harlan JM. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 1999;93:3831-8.
20. HayashiM, Takeshita K, Inden Y, et al. Platelet activation and Induction of tissue factor In acute and chronic atrial fibrillation: Involvement of mononuclear cell-platelet Interaction. Thromb Res 2011;128:e113-8.
21. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation Is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 2008;51:1790-3.
22. Nakamura Y, Nakamura K, Fukushima-Kusano K, et al. Tissue factor expression In atrial endothelia associatedwith nonvalvular atrial fibrillation: possible Involvement In Intracardiac thrombogenesis. Thromb Res 2003;111:137-42.
23. HoumsseM, Tyler J, Kalbfleisch S. Supraventricular tachycardia causing heart failure. Curr Opin Cardiol 2011;26:261-9.
24. Bauer A,McDonald AD, Donahue JK. PathoPhysiological findings In amodel of persistent atrial fibrillation and severe congestive heart failure. Cardiovasc Res 2004;61: 764-70.
25. Zhao J, Li J, Li W, et al. Effects of spironolactone on atrial structural remodelling In a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol 2010;159:1584-94.
26. Heinke MY, Yao M, Chang D, Einstein R, dos Remedios CG. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure. Cardiovasc Res 2001;49:127-34.
27. Moe GW, Naik G, Konig A, Lu X, Feng Q. Early and persistent activation ofmyocardial apoptosis, bax and caspases: Insights Into mechanisms of progression of heart failure. PathoPhysiology 2002;8:183-92.
28. Morris PD, Robinson T, Channer KS. Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities. Postgrad Med J 2012;88:706-12.
29. De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC.Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res 2011;89:754-65.
30. Pizzale S, Lemery R, Green MS, GollobMH, Tang AS, BirnieDH. Frequency and predictors of tachycardia-induced cardiomyopathy In patientswith persistent atrial flutter. Can J Cardiol 2009;25:469-72.
31. Xu XL, Ji H, Gu SY, Shao Q, Huang QJ, Cheng YP. Cardioprotective effects of Astragali Radix against Isoproterenol-inducedmyocardial Injury In rats and Its possiblemechanism. Phytother Res 2008;22:389-94.
32. Schotten U, Greiser M, Benke D, et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res 2002;53:192-201.
33. Boulanger CM, Amabile N, Guerin AP, et al. In vivo shear stress determines circulating levels of endothelialmicroparticles In end-stage renal disease.Hypertension 2007;49: 902-8.
34. Grabowski EF, Reininger AJ, Petteruti PG, Tsukurov O, Orkin RW. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway Inhibitor. Arterioscler Thromb Vasc Biol 2001;21:157-62.
35. Cai H, Li Z, Goette A, et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production In atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 2002;106:2854-8.
36. Mazzolai L, Silacci P, Bouzourene K, Daniel F, BrunnerH, Hayoz D. Tissue factor activity Is upregulated In human endothelial cells exposed to oscillatory shear stress. Thromb Haemost 2002;87:1062-8.
37. Gramley F, Lorenzen J, Jedamzik B, et al. Atrial fibrillation Is associated with cardiac hypoxia. Cardiovasc Pathol 2010;19:102-11.
38. Liao XD, TangAH, Chen Q, et al. Role of Ca2+signaling In Initiation of stretch-induced apoptosis In neonatal heart cells. Biochem Biophys Res Commun 2003;310:405-11.
39. Gao SP, Deng XT, Ge LJ, et al. Is Inflammation linked to thrombogenesis In atrial fibrillation? Int J Cardiol;149:260-1.
40. Marcus GM, Smith LM, Ordovas K, et al. Intracardiac and extracardiac markers of Inflammation during atrial fibrillation. Heart Rhythm 2010;7:149-54.
41. Han W, Fu S, Wei N, et al. Nitric oxide overproduction derived from Inducible nitric oxide synthase Increases cardiomyocyte apoptosis In human atrial fibrillation. Int J Cardiol 2008;130:165-73.
42. Devaraj S, Kumaresan PR, Jialal I. C-reactive protein Induces release of both endothelial microparticles and circulating endothelial cells In vitro and In vivo: further evidence of endothelial dysfunction. Clin Chem 2011;57:1757-61.
43. Habersberger J, Strang F, Scheichl A, et al. Circulating microparticles generate and transport monomeric C-reactive protein In patients with myocardial Infarction. Cardiovasc Res 2012;96:64-72.
44. Richter B, Gwechenberger M, Socas A, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with Inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol 2012;101:217-25.
45. Lin YJ, TsaoHM, Chang SL, et al. Prognostic Implications of the high-sensitive C-reactive protein In the catheter ablation of atrial fibrillation. Am J Cardiol 2010;105:495-501.
46. Kornej J, Reinhardt C, Kosiuk J, et al. Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and Its relationwith rhythmoutcome. PLoS One 2012;7:e44165.
47. Koyama T, Tada H, Sekiguchi Y, et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J Am Coll Cardiol 2010;56:1463-72.
48. Deftereos S, Giannopoulos G, Kossyvakis C, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein Isolation: a randomized controlled study. J Am Coll Cardiol 2012;60:1790-6.
49. Willoughby SR, Roberts-Thomson RL, Lim HS, et al. Atrial platelet reactivity In patients with atrial fibrillation. Heart Rhythm 2010;7:1178-83.
50. de Divitiis M, Omran H, Rabahieh R, et al. Right atrial appendage thrombosis In atrial fibrillation: Its frequency and Its clinical predictors. Am J Cardiol 1999;84:1023-8.
51. Di Biase L, Santangeli P, AnselminoM, et al. Does the left atrial appendagemorphology correlate with the risk of stroke In patientswith atrial fibrillation? Results fromamulticenter study. J Am Coll Cardiol 2012;60:531-8.
52. Subramaniam B, Riley MF, Panzica PJ, Manning WJ. Transesophageal echocardiographic assessment of right atrial appendage anatomy and function: comparison with the left atrial appendage and Implications for local thrombus formation. J Am Soc Echocardiogr 2006;19:429-33.
53. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis In atrial fibrillation: Virchow's triad revisited. Lancet 2009;373:155-66.
54. Feng D, D'Agostino RB, Silbershatz H, et al. Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol 2001;87:168-71.
55. Wang H, Yan HM, Tang MX, et al. Increased serum levels of microvesicles In nonvalvular atrial fibrillation determinated by ELiSA using a specific monoclonal antibody AD-1. Clin Chim Acta 2010;411:1700-4.
56. Azzam H, Zagloul M. Elevated platelet microparticle levels In valvular atrial fibrillation. Hematology 2009;14:357-60.
57. Bulava A, Slavik L, FialaM, et al. Endothelial damage and activation of the hemostatic system during radiofrequency catheter Isolation of pulmonary veins. J Interv Card ElectroPhysiol 2004;10:271-9.
58. HochholzerW, Schlittenhardt D, Arentz T, et al. Platelet activation andmyocardial necrosis In patients undergoing radiofrequency and cryoablation of Isthmus-dependent atrial flutter. Europace 2007;9:490-5.
59. Bertaglia E, Zoppo F, Tondo C, et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: amulticenter prospective registry on procedural safety. Heart Rhythm 2007;4:1265-71.
60. Herrera Siklody C, Arentz T, Minners J, et al. Cellular damage, platelet activation, and Inflammatory response after pulmonary vein Isolation: a randomized study comparing radiofrequency ablation with cryoablation. Heart Rhythm 2012;9:189-96.
61. Khairy P, Chauvet P, Lehmann J, et al. Lower Incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003;107:2045-50.
62. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm ElectroPhysiol 2010;3:32-8.
63. Christersson C, JohnellM, Siegbahn A. The Influence of direct thrombin Inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression. Thromb Res 2010;126:e327-33.
64. Weber R,Minners J, Restle C, et al. Pulmonary edema after extensive radiofrequency ablation for atrial fibrillation. J Cardiovasc ElectroPhysiol 2008;19:748-52.
65. Osmancik P, Peroutka Z, Budera P, et al. Decreased apoptosis following successful ablation of atrial fibrillation. Cardiology 2010;116:302-7.
66. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery systemfor RANTES promotingmonocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005;25:1512-8.
67. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor Into developing thrombi In vivo Is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585-98.
68. Ramacciotti E, Hawley AE, Farris DM, et al. Leukocyte-and platelet-derived microparticles correlate with thrombus weight and tissue factor activity In an experimental mouse model of venous thrombosis. Thromb Haemost 2009;101:748-54.
69. Morel O, Pereira B, Averous G, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial Infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009;204:636-41.
70. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor Induction In a JNK1 signaling pathway. J Biol Chem 1999;274: 23111-8.
71. Essayagh S, Xuereb JM, TerrisseAD, Tellier-Cirioni L, Pipy B, Sie P. Microparticles from apoptoticmonocytes Induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism. Thromb Haemost 2007;98:831-7.
72. Martin S, Tesse A, Hugel B, et al. Shed membrane particles from T lymphocytes Impair endothelial function and regulate endothelial protein expression. Circulation 2004;109:1653-9.
73. Essayagh S, Brisset AC, Terrisse AD, et al. Microparticles from apoptotic vascular smooth muscle cells Induce endothelial dysfunction, a phenomenon prevented by beta3-Integrin antagonists. Thromb Haemost 2005;94:853-8.
74. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids In platelet microparticles. J Clin Invest 1997;99: 2118-27.
75. Mukherjee R, Herron AR, Lowry AS, et al. Selective Induction of matrix metalloproteinases and tissue Inhibitor of metalloproteinases In atrial and ventricular myocardium In patients with atrial fibrillation. Am J Cardiol 2006;97: 532-7.
76. de LizarrondoSM, Roncal C, Calvayrac O, et al. Synergistic effect of thrombin and CD40 ligand on endothelialmatrixmetalloproteinase-10 expression andmicroparticle generation In vitro and In vivo. Arterioscler Thromb Vasc Biol.
77. Lozito TP, Tuan RS. Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol 2012;227:534-49.
78. Okumura Y,Watanabe I, Nakai T, et al. Impact of biomarkers of Inflammation and extracellularmatrix turnover on the outcome of atrial fibrillation ablation: Importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence. J Cardiovasc ElectroPhysiol 2011;22:987-93.
79. Dejouvencel T, Doeuvre L, Lacroix R, et al. Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood; 115; 2048-56.
80. LukasikM,Michalak S, Dworacki G, et al. Reactive leptin resistance and the profile of platelet activation In acute Ischaemic stroke patients. Thromb Haemost 2012;108: 107-18.
81. Conway DS,Heeringa J, VanDer KuipDA, et al. Atrial fibrillation and the prothrombotic state In the elderly: the Rotterdam Study. Stroke 2003;34:413-7.
82. Morel O,Hugel B, Jesel L, et al. Sustained elevated amounts of circulating procoagulant membranemicroparticles and soluble GPV after acutemyocardial Infarction In diabetes mellitus. Thromb Haemost 2004;91:345-53.